Genetic Determinants of Kawasaki Disease

NCT03861130 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1379

Last updated 2022-11-17

No results posted yet for this study

Summary

Kawasaki disease (KD) is an acute self-limited vasculitis of infancy and early childhood. Most patients recover without sequelae although the inflammatory process causes permanent damage to the coronary arteries in 20-25% of untreated children. An infectious aetiology is suspected, but the causative agent has not been identified. The investigators aim to identify the genes underlying both susceptibility to Kawasaki disease, and the development of coronary artery aneurysms.

Conditions

  • Kawasaki Disease
  • Atypical Kawasaki Disease

Sponsors & Collaborators

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER
  • University Hospitals Bristol and Weston NHS Foundation Trust

    collaborator OTHER
  • Great Ormond Street Hospital for Children NHS Foundation Trust

    collaborator OTHER
  • UK Kawasaki Support Group

    collaborator UNKNOWN
  • Imperial College Healthcare NHS Trust

    collaborator OTHER
  • University Hospitals of North Midlands NHS Trust

    collaborator OTHER
  • Burton Hospitals NHS Foundation Trust

    collaborator OTHER
  • York Teaching Hospitals NHS Foundation Trust

    collaborator OTHER
  • Shrewsbury and Telford Hospitals NHS Trust

    collaborator OTHER
  • East Suffolk and North Essex NHS Foundation Trust

    collaborator OTHER
  • New Cross Hospital

    collaborator OTHER
  • Darlington Memorial Hospital

    collaborator UNKNOWN
  • Torbay Hospital

    collaborator UNKNOWN
  • Peterborough City Hospital

    collaborator UNKNOWN
  • University Hospitals Coventry and Warwickshire NHS Trust

    collaborator OTHER
  • University Hospital of North Tees

    collaborator UNKNOWN
  • Cambridge University Hospitals NHS Foundation Trust

    collaborator OTHER
  • Royal Cornwall Hospitals Trust

    collaborator OTHER
  • Birmingham Children's Hospital

    collaborator OTHER
  • University Hospital Birmingham NHS Foundation Trust

    collaborator OTHER
  • Wye Valley NHS Trust

    collaborator OTHER_GOV
  • South Tees Hospitals NHS Foundation Trust

    collaborator OTHER
  • Leeds General Infirmary

    collaborator UNKNOWN
  • Bradford Royal Infirmary

    collaborator OTHER
  • University Hospitals of Morecambe Bay NHS Trust

    collaborator OTHER
  • Calderdale and Huddersfield NHS Foundation Trust

    collaborator OTHER
  • St. Richard's Hospital

    collaborator OTHER
  • Pinderfields General Hospital

    collaborator UNKNOWN
  • Worthing Hospital

    collaborator UNKNOWN
  • Airedale General Hospital

    collaborator UNKNOWN
  • Sheffield Children's NHS Foundation Trust

    collaborator OTHER
  • Northwick Park Hospital

    collaborator OTHER
  • West Middlesex Hospital

    collaborator UNKNOWN
  • Royal Albert Edward Infirmary

    collaborator UNKNOWN
  • Macclesfield District General Hospital

    collaborator UNKNOWN
  • Royal Oldham Hospital

    collaborator UNKNOWN
  • Stepping Hill Hospital

    collaborator UNKNOWN
  • North Manchester General Hospital

    collaborator UNKNOWN
  • Royal Bolton Hospital NHS Foundation Trust

    collaborator OTHER
  • Kingston Hospital NHS Trust

    collaborator OTHER
  • Tameside Hospital NHS Foundation Trust

    collaborator OTHER
  • East Surrey Hospital

    collaborator UNKNOWN
  • St. George's Hospital, London

    collaborator OTHER
  • Royal Alexandra Children's Hospital

    collaborator OTHER
  • Imperial College London

    lead OTHER

Principal Investigators

  • Professor M Levin · Imperial College London

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-25
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03861130 on ClinicalTrials.gov